Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126438431 | 12643843 | 1 | I | 20160729 | 20160811 | 20160811 | EXP | GB-MHRA-EYC 00142914 | GB-TEVA-682688ACC | TEVA | 87.00 | YR | M | Y | 0.00000 | 20160811 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126438431 | 12643843 | 1 | PS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | CHANGED TO INTRAVENOUS USE AFTER SUSPECT REACTION. | Y | U | 18413 | 40 | MG | ||||||
| 126438431 | 12643843 | 2 | SS | IBUPROFEN. | IBUPROFEN | 1 | Oral | Y | U | 0 | |||||||||
| 126438431 | 12643843 | 3 | C | ADCAL-D3 | CALCIUM CARBONATECHOLECALCIFEROL | 1 | 0 | ||||||||||||
| 126438431 | 12643843 | 4 | C | RANITIDINE. | RANITIDINE | 1 | 0 | ||||||||||||
| 126438431 | 12643843 | 5 | C | SIMVASTATIN. | SIMVASTATIN | 1 | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126438431 | 12643843 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126438431 | 12643843 | Acute kidney injury | |
| 126438431 | 12643843 | Malaise |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |